@dr_imranm @DeepDastidar @onco_cardiology @NHSBartsHealth @EuroCardioOnc @AnaBaracCardio @ecocardio_cl @CardioOncology @avirupguha @sdent_duke @ICOSociety @DrJESalem @oncology_cardio @Dr_Mike_Fradley @DrRyanPDaly More evidence for ARBs and for beta blocker
RT @JACCJournals: In a meta-analysis including a total of 2,177 breast cancer patients, dexrazoxane reduced the risk of #heartfailure and c…
Efficacy of Dexrazoxane in Preventing Anthracycline Cardiotoxicity in Breast Cancer https://t.co/ClMgjfGnYI
RT @sarahhudsonuk: Dexrazoxane to protect against anthracycline-induced cardiotoxicity? Meta analysis in @JACCJournals suggests yes, but…
RT @womencardio_onc: Efficacy of Dexrazoxane in Preventing Anthracycline Cardiotoxicity in Breast Cancer https://t.co/l7BAKnAFQ4
RT @OncoCard_Ganken: Efficacy of Dexrazoxane in Preventing #Anthracycline Cardiotoxicity in #BreastCancer https://t.co/BuKgkaZ200 #Cardiot…
Efficacy of Dexrazoxane in Preventing #Anthracycline Cardiotoxicity in #BreastCancer https://t.co/BuKgkaZ200 #Cardiotoxicity #Dexrazoxane #prevention #cardioprotection #survivorship 日本でも使える選択肢の一つになると良いのですが。。 #CardioOnc #CardioJapan
RT @sarahhudsonuk: Dexrazoxane to protect against anthracycline-induced cardiotoxicity? Meta analysis in @JACCJournals suggests yes, but…
Take a look @md_arianemacedo
RT @sarahhudsonuk: Dexrazoxane to protect against anthracycline-induced cardiotoxicity? Meta analysis in @JACCJournals suggests yes, but…
RT @sarahhudsonuk: Dexrazoxane to protect against anthracycline-induced cardiotoxicity? Meta analysis in @JACCJournals suggests yes, but…
RT @JACCJournals: In a meta-analysis including a total of 2,177 breast cancer patients, dexrazoxane reduced the risk of #heartfailure and c…
RT @sarahhudsonuk: Dexrazoxane to protect against anthracycline-induced cardiotoxicity? Meta analysis in @JACCJournals suggests yes, but…
RT @sarahhudsonuk: Dexrazoxane to protect against anthracycline-induced cardiotoxicity? Meta analysis in @JACCJournals suggests yes, but…
Dexrazoxane to protect against anthracycline-induced cardiotoxicity? Meta analysis in @JACCJournals suggests yes, but notes quality of available evidence low and RCT required before systemic implementation in clinical practice https://t.co/JwEuTidE3e
RT @CampbellMDPhD: Dexrazoxane ⬇️risk of 💔failure/events in patients w breast cancer + anthracycline chemo +/- trastuzumab w/o impacting ca…
RT @CampbellMDPhD: Dexrazoxane ⬇️risk of 💔failure/events in patients w breast cancer + anthracycline chemo +/- trastuzumab w/o impacting ca…
Dexrazoxane ⬇️risk of 💔failure/events in patients w breast cancer + anthracycline chemo +/- trastuzumab w/o impacting cancer outcomes. @md_arianemacedo Article: https://t.co/MzeZxkCesl Editorial: https://t.co/sD2oMXdEfi Another excellent #jaccco paper! #Ca
RT @thaiscoutinhoCV: Kudos to my 🇧🇷 colleagues for this important meta-analysis! @pabeda1 @SBarrosGomes @WiefelsC : vejam esse artigo do JA…
RT @JACCJournals: In a meta-analysis including a total of 2,177 breast cancer patients, dexrazoxane reduced the risk of #heartfailure and c…
RT @thaiscoutinhoCV: Kudos to my 🇧🇷 colleagues for this important meta-analysis! @pabeda1 @SBarrosGomes @WiefelsC : vejam esse artigo do JA…
RT @thaiscoutinhoCV: Kudos to my 🇧🇷 colleagues for this important meta-analysis! @pabeda1 @SBarrosGomes @WiefelsC : vejam esse artigo do JA…
RT @JACCJournals: In a meta-analysis including a total of 2,177 breast cancer patients, dexrazoxane reduced the risk of #heartfailure and c…
RT @DrRajivsankar: https://t.co/tDLLAkjLvT @arjunkg Should this be standard therapy? https://t.co/hKn3R5Tqo1
RT @BSHeartFailure: Surely should be being used as standard? https://t.co/SNEfDJoLXo
RT @DrRajivsankar: https://t.co/tDLLAkjLvT @arjunkg Should this be standard therapy? https://t.co/hKn3R5Tqo1
RT @JACCJournals: In a meta-analysis including a total of 2,177 breast cancer patients, dexrazoxane reduced the risk of #heartfailure and c…
RT @JACCJournals: In a meta-analysis including a total of 2,177 breast cancer patients, dexrazoxane reduced the risk of #heartfailure and c…
RT @JACCJournals: In a meta-analysis including a total of 2,177 breast cancer patients, dexrazoxane reduced the risk of #heartfailure and c…
RT @thaiscoutinhoCV: Kudos to my 🇧🇷 colleagues for this important meta-analysis! @pabeda1 @SBarrosGomes @WiefelsC : vejam esse artigo do JA…
RT @DrRajivsankar: https://t.co/tDLLAkjLvT @arjunkg Should this be standard therapy? https://t.co/hKn3R5Tqo1
Kudos to my 🇧🇷 colleagues for this important meta-analysis! @pabeda1 @SBarrosGomes @WiefelsC : vejam esse artigo do JACC por autores brasileiros!
RT @JACCJournals: In a meta-analysis including a total of 2,177 breast cancer patients, dexrazoxane reduced the risk of #heartfailure and c…
RT @JACCJournals: In a meta-analysis including a total of 2,177 breast cancer patients, dexrazoxane reduced the risk of #heartfailure and c…
RT @JACCJournals: In a meta-analysis including a total of 2,177 breast cancer patients, dexrazoxane reduced the risk of #heartfailure and c…
RT @JACCJournals: In a meta-analysis including a total of 2,177 breast cancer patients, dexrazoxane reduced the risk of #heartfailure and c…
RT @DrRajivsankar: https://t.co/tDLLAkjLvT @arjunkg Should this be standard therapy? https://t.co/hKn3R5Tqo1
RT @DrRajivsankar: https://t.co/tDLLAkjLvT @arjunkg Should this be standard therapy? https://t.co/hKn3R5Tqo1
RT @DrRajivsankar: https://t.co/tDLLAkjLvT @arjunkg Should this be standard therapy? https://t.co/hKn3R5Tqo1
https://t.co/tDLLAkjLvT @arjunkg Should this be standard therapy? https://t.co/hKn3R5Tqo1
RT @JACCJournals: In a meta-analysis including a total of 2,177 breast cancer patients, dexrazoxane reduced the risk of #heartfailure and c…
RT @JACCJournals: In a meta-analysis including a total of 2,177 breast cancer patients, dexrazoxane reduced the risk of #heartfailure and c…
RT @JACCJournals: In a meta-analysis including a total of 2,177 breast cancer patients, dexrazoxane reduced the risk of #heartfailure and c…
RT @JACCJournals: In a meta-analysis including a total of 2,177 breast cancer patients, dexrazoxane reduced the risk of #heartfailure and c…
RT @JACCJournals: In a meta-analysis including a total of 2,177 breast cancer patients, dexrazoxane reduced the risk of #heartfailure and c…
RT @JACCJournals: In a meta-analysis including a total of 2,177 breast cancer patients, dexrazoxane reduced the risk of #heartfailure and c…
RT @JACCJournals: In a meta-analysis including a total of 2,177 breast cancer patients, dexrazoxane reduced the risk of #heartfailure and c…
RT @JACCJournals: In a meta-analysis including a total of 2,177 breast cancer patients, dexrazoxane reduced the risk of #heartfailure and c…
RT @BSHeartFailure: Surely should be being used as standard? https://t.co/SNEfDJoLXo
RT @htp_ic: Avances en insuficiencia cardíaca y cardiooncologia @SAC_54 https://t.co/S58xxZk16c
🤓 interesante ! 👀
RT @JACCJournals: In a meta-analysis including a total of 2,177 breast cancer patients, dexrazoxane reduced the risk of #heartfailure and c…
RT @JACCJournals: In a meta-analysis including a total of 2,177 breast cancer patients, dexrazoxane reduced the risk of #heartfailure and c…
RT @JACCJournals: In a meta-analysis including a total of 2,177 breast cancer patients, dexrazoxane reduced the risk of #heartfailure and c…
RT @htp_ic: Avances en insuficiencia cardíaca y cardiooncologia @SAC_54 https://t.co/S58xxZk16c
Avances en insuficiencia cardíaca y cardiooncologia @SAC_54
RT @JACCJournals: In a meta-analysis including a total of 2,177 breast cancer patients, dexrazoxane reduced the risk of #heartfailure and c…
Great work @md_arianemacedo Proud to be a part of this project
RT @JACCJournals: In a meta-analysis including a total of 2,177 breast cancer patients, dexrazoxane reduced the risk of #heartfailure and c…
Surely should be being used as standard?
RT @JACCJournals: In a meta-analysis including a total of 2,177 breast cancer patients, dexrazoxane reduced the risk of #heartfailure and c…
RT @JACCJournals: In a meta-analysis including a total of 2,177 breast cancer patients, dexrazoxane reduced the risk of #heartfailure and c…
RT @JACCJournals: In a meta-analysis including a total of 2,177 breast cancer patients, dexrazoxane reduced the risk of #heartfailure and c…
RT @JACCJournals: In a meta-analysis including a total of 2,177 breast cancer patients, dexrazoxane reduced the risk of #heartfailure and c…
RT @JACCJournals: In a meta-analysis including a total of 2,177 breast cancer patients, dexrazoxane reduced the risk of #heartfailure and c…
RT @JACCJournals: In a meta-analysis including a total of 2,177 breast cancer patients, dexrazoxane reduced the risk of #heartfailure and c…
In a meta-analysis including a total of 2,177 breast cancer patients, dexrazoxane reduced the risk of #heartfailure and cardiac events without a significant impact in cancer outcomes: https://t.co/g67spYXX4G #JACCCardioOnc https://t.co/ukbZum1ByF
RT @womencardio_onc: Efficacy of Dexrazoxane in Preventing Anthracycline Cardiotoxicity in Breast Cancer https://t.co/l7BAKnAFQ4
RT @womencardio_onc: Efficacy of Dexrazoxane in Preventing Anthracycline Cardiotoxicity in Breast Cancer https://t.co/l7BAKnAFQ4
Congratulations!!
RT @womencardio_onc: Efficacy of Dexrazoxane in Preventing Anthracycline Cardiotoxicity in Breast Cancer https://t.co/l7BAKnAFQ4
RT @womencardio_onc: Efficacy of Dexrazoxane in Preventing Anthracycline Cardiotoxicity in Breast Cancer https://t.co/l7BAKnAFQ4
RT @womencardio_onc: Efficacy of Dexrazoxane in Preventing Anthracycline Cardiotoxicity in Breast Cancer https://t.co/l7BAKnAFQ4
RT @womencardio_onc: Efficacy of Dexrazoxane in Preventing Anthracycline Cardiotoxicity in Breast Cancer https://t.co/l7BAKnAFQ4
RT @md_arianemacedo: So honoured to see my paper on the very first issue of #JACCCO. Hapiness is my word for today. Efficacy of Dexrazoxane…
Efficacy of Dexrazoxane in Preventing Anthracycline Cardiotoxicity in Breast Cancer https://t.co/l7BAKnAFQ4
RT @md_arianemacedo: So honoured to see my paper on the very first issue of #JACCCO. Hapiness is my word for today. Efficacy of Dexrazoxane…
RT @md_arianemacedo: So honoured to see my paper on the very first issue of #JACCCO. Hapiness is my word for today. Efficacy of Dexrazoxane…
RT @md_arianemacedo: So honoured to see my paper on the very first issue of #JACCCO. Hapiness is my word for today. Efficacy of Dexrazoxane…
RT @md_arianemacedo: So honoured to see my paper on the very first issue of #JACCCO. Hapiness is my word for today. Efficacy of Dexrazoxane…
RT @md_arianemacedo: So honoured to see my paper on the very first issue of #JACCCO. Hapiness is my word for today. Efficacy of Dexrazoxane…
RT @md_arianemacedo: So honoured to see my paper on the very first issue of #JACCCO. Hapiness is my word for today. Efficacy of Dexrazoxane…
RT @md_arianemacedo: So honoured to see my paper on the very first issue of #JACCCO. Hapiness is my word for today. Efficacy of Dexrazoxane…
RT @md_arianemacedo: So honoured to see my paper on the very first issue of #JACCCO. Hapiness is my word for today. Efficacy of Dexrazoxane…
RT @md_arianemacedo: So honoured to see my paper on the very first issue of #JACCCO. Hapiness is my word for today. Efficacy of Dexrazoxane…
RT @patricia_tfm: Congrats @md_arianemacedo ! Great meta-analysis! 👏👏👏👏 https://t.co/bnEtIprgsP
Congrats @md_arianemacedo ! Great meta-analysis! 👏👏👏👏
RT @md_arianemacedo: So honoured to see my paper on the very first issue of #JACCCO. Hapiness is my word for today. Efficacy of Dexrazoxane…
RT @md_arianemacedo: So honoured to see my paper on the very first issue of #JACCCO. Hapiness is my word for today. Efficacy of Dexrazoxane…
RT @md_arianemacedo: So honoured to see my paper on the very first issue of #JACCCO. Hapiness is my word for today. Efficacy of Dexrazoxane…
RT @md_arianemacedo: So honoured to see my paper on the very first issue of #JACCCO. Hapiness is my word for today. Efficacy of Dexrazoxane…
RT @md_arianemacedo: So honoured to see my paper on the very first issue of #JACCCO. Hapiness is my word for today. Efficacy of Dexrazoxane…
Congrats my dear friend!!!! Well deserved!!!!!! 👏👏👏👏👏👏👏
RT @md_arianemacedo: So honoured to see my paper on the very first issue of #JACCCO. Hapiness is my word for today. Efficacy of Dexrazoxane…
RT @md_arianemacedo: So honoured to see my paper on the very first issue of #JACCCO. Hapiness is my word for today. Efficacy of Dexrazoxane…
RT @md_arianemacedo: So honoured to see my paper on the very first issue of #JACCCO. Hapiness is my word for today. Efficacy of Dexrazoxane…
RT @md_arianemacedo: So honoured to see my paper on the very first issue of #JACCCO. Hapiness is my word for today. Efficacy of Dexrazoxane…
RT @md_arianemacedo: So honoured to see my paper on the very first issue of #JACCCO. Hapiness is my word for today. Efficacy of Dexrazoxane…